Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan

被引：22
|
作者：
Richards, S
Umbreit, JN
Fanucchi, MP
Giblin, J
Khuri, F
机构：
[1] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA
来源：
SOUTHERN MEDICAL JOURNAL | 2003年 / 96卷 / 10期
关键词：
citalopram; irinotecan; rhabdomyolysis; selective serotonin reuptake inhibitors;
D O I：
10.1097/01.SMJ.0000084311.35864.D6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 74-year-old man was admitted with rhabdomyolysis after undergoing initial treatment for gastrointestinal cancer with irinotecan. The syndrome partially resolved after the discontinuation of all of his usual medications, including his chronic selective serotonin reuptake inhibitor (SSRI). The rhabdomyolysis was exacerbated upon reinitiation of the SSRI and disappeared when the SSRI was discontinued. The combination of irinotecan and SSRI resulted in potentially lethal rhabdomyolysis.
引用
收藏
页码：1031 / 1033
页数：3
相关论文
共 50 条
  • [21] A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation
    Tseng, Yu-Lun
    Chiang, Meng-Ling
    Huang, Tur-Fu
    Su, Kuan-Pin
    Lane, Hsien-Yuan
    Lai, Yu-Chen
    THROMBOSIS RESEARCH, 2010, 126 (06) : 517 - 523
  • [22] Serotonin Hypothesis of Autism: Implications for Selective Serotonin Reuptake Inhibitor Use during Pregnancy
    Harrington, Rebecca A.
    Lee, Li-Ching
    Crum, Rosa M.
    Zimmerman, Andrew W.
    Hertz-Picciotto, Irva
    AUTISM RESEARCH, 2013, 6 (03) : 149 - 168
  • [23] Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa
    Kaye, W
    Gendall, K
    Strober, M
    BIOLOGICAL PSYCHIATRY, 1998, 44 (09) : 825 - 838
  • [24] A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy
    Hudd, Timothy R.
    Blake, Christie S.
    Rimola-Dejesus, Yahiada
    Nguyen, Thu-Trang
    Zaiken, Kathy
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (02) : 206 - 212
  • [25] Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
    Julie A. Vignato
    S. Banu Gumusoglu
    Heather A. Davis
    Sabrina M. Scroggins
    Wendy S. Hamilton
    Debra S. Brandt
    Gary L. Pierce
    Boyd A. Knosp
    Donna A. Santillan
    Mark K. Santillan
    Reproductive Sciences, 2023, 30 : 701 - 712
  • [26] Selective Serotonin Reuptake Inhibitor Use in Pregnancy and Protective Mechanisms in Preeclampsia
    Vignato, Julie A.
    Gumusoglu, S. Banu
    Davis, Heather A.
    Scroggins, Sabrina M.
    Hamilton, Wendy S.
    Brandt, Debra S.
    Pierce, Gary L.
    Knosp, Boyd A.
    Santillan, Donna A.
    Santillan, Mark K.
    REPRODUCTIVE SCIENCES, 2023, 30 (02) : 701 - 712
  • [27] EFFECTIVE TREATMENT OF POSTSTROKE DEPRESSION WITH THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR CITALOPRAM
    ANDERSEN, G
    VESTERGAARD, K
    LAURITZEN, L
    STROKE, 1994, 25 (06) : 1099 - 1104
  • [28] Selective Serotonin Reuptake Inhibitor Drug Interactions in Patients Receiving Statins
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2014, 75 (02) : E95 - E99
  • [29] N-methyl-citalopram: A quaternary selective serotonin reuptake inhibitor
    Bismuth-Evenzal, Yona
    Roz, Netta
    Gurwitz, David
    Rehavi, Moshe
    BIOCHEMICAL PHARMACOLOGY, 2010, 80 (10) : 1546 - 1552
  • [30] Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
    Ashbury, Janet E.
    Levesque, Linda E.
    Beck, Patricia A.
    Aronson, Kristen J.
    FRONTIERS IN ONCOLOGY, 2012, 2
12345